DexCom Inc

DXCM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
&nLOCK|D<kM!LOCK|&qd>gG&

DexCom Earnings: Smooth Sailing Signals Full Recovery From 2025

DexCom's third-quarter revenue rose by 11%, boosted by US growth of 14% while international sales rose 5%. Gross margin rose to 64%, roughly 380 basis points higher than in the prior-year period.

Sponsor Center